NYSE
27.86USD
+2.26 (+8.83%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
13.9B
P/E
—
EPS
—
Beta
1.69
52W range
13.76-27.963
Day range
26.98–27.98
Open
27.46
Prev close
25.60
Volume
3M
Avg volume
5.9M
Dividend
0.00
IPO
2018-09-20
https://www.zacks.com/stock/news/2968293/elanco-animal-health-incorporated-elan-q2-earnings-and-revenues-beat-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2968293 · 8/5/2026+1.00
https://www.prnewswire.com/news-releases/elanco-announces-usda-approval-of-trucan-ultra-lyme-l4-the-first-and-only-12-ml-combination-vaccine-for-lyme-and-leptospirosis-for-dogs-302800250.html · 6/15/2026+1.00
https://www.youtube.com/watch?v=47RRTUhkkTk · 6/4/2026+0.60
https://www.marketbeat.com/instant-alerts/elanco-animal-health-q1-earnings-call-highlights-2026-05-10/ · 5/10/2026+1.00
https://www.zacks.com/stock/news/2915539/elanco-animal-health-incorporated-elan-beats-q1-earnings-and-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2915539 · 5/6/2026
https://www.foxbusiness.com/economy/us-jobs-report-march-2026 · 4/3/2026+0.00
https://www.defenseworld.net/2026/03/08/citigroup-inc-cuts-stake-in-elanco-animal-health-incorporated-elan.html · 3/8/2026-0.40
https://www.globenewswire.com/news-release/2026/02/26/3246033/0/en/Amlan-International-and-Elanco-Collaborate-on-Japanese-Educational-Seminars-Focused-on-Calf-Health.html · 2/26/2026+0.30
https://www.zacks.com/stock/news/2874251/elanco-animal-health-elan-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2874251 · 2/24/2026+0.60
https://www.defenseworld.net/2026/02/22/channing-capital-management-llc-reduces-stake-in-elanco-animal-health-incorporated-elan.html · 2/22/2026-0.20
https://www.prnewswire.com/news-releases/veterinary-pharmaceuticals-market-worth-39-37-billion-by-2031--marketsandmarkets-302688531.html · 2/16/2026+0.60
https://www.prnewswire.com/news-releases/feline-hyperthyroidism-virbac-acquires-felanorm-302645264.html · 12/17/2025+0.00
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works